The next board meeting for Stoke Therapeutics Inc is on 09 Sep 2025 for the purpose of Morgan Stanley 23rd Annual Global Healthcare ConferenceSee details
Stoke Therapeutics Inc has a share price target of US$ 24, revenue growth forecast of 407.6%, and profit growth estimate of 116.6% for FY25, based on top 11 analyst calls.